Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,629 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacokinetic interactions between BMS-626529, the active moiety of the HIV-1 attachment inhibitor prodrug BMS-663068, and ritonavir or ritonavir-boosted atazanavir in healthy subjects.
Zhu L, Hruska M, Hwang C, Shah V, Furlong M, Hanna GJ, Bertz R, Landry IS. Zhu L, et al. Among authors: shah v. Antimicrob Agents Chemother. 2015 Jul;59(7):3816-22. doi: 10.1128/AAC.04914-14. Epub 2015 Apr 13. Antimicrob Agents Chemother. 2015. PMID: 25870057 Free PMC article. Clinical Trial.
Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase II, Randomized, Double-Blind, Placebo-Controlled Trial.
Morand E, Pike M, Merrill JT, van Vollenhoven R, Werth VP, Hobar C, Delev N, Shah V, Sharkey B, Wegman T, Catlett I, Banerjee S, Singhal S. Morand E, et al. Among authors: shah v. Arthritis Rheumatol. 2023 Feb;75(2):242-252. doi: 10.1002/art.42391. Epub 2022 Nov 11. Arthritis Rheumatol. 2023. PMID: 36369798 Free PMC article. Clinical Trial.
Plain Language Summary of the PAISLEY study: deucravacitinib as a treatment for people with systemic lupus erythematosus.
Morand EF, Pike M, Merrill J, F van Vollenhoven R, Werth VP, Hobar C, Delev N, Shah V, Sharkey B, Wegman T, Catlett I, Banerjee S, Singhal S. Morand EF, et al. Among authors: shah v. Expert Opin Investig Drugs. 2024 May;33(5):431-440. doi: 10.1080/13543784.2024.2337736. Epub 2024 May 29. Expert Opin Investig Drugs. 2024. PMID: 38807572
Design of PEG-Based Hydrogels as Soft Ionic Conductors.
Rodriguez-Rivera GJ, Xu F, Laude M, Shah V, Nkansah A, Bashe D, Lan Z, Chwatko M, Cosgriff-Hernandez E. Rodriguez-Rivera GJ, et al. Among authors: shah v. J Biomed Mater Res A. 2025 Jan;113(1):e37840. doi: 10.1002/jbm.a.37840. J Biomed Mater Res A. 2025. PMID: 39578947
Ferroptosis of select skin epithelial cells initiates and maintains chronic systemic immune-mediated psoriatic disease.
Vats K, Tian H, Singh K, Tyurina YY, Sparvero LJ, Tyurin VA, Kruglov O, Chang A, Wang J, Green F, Samovich SN, Zhang J, Chattopadhyay A, Murray N, Shah VK, Mathers AR, Chandran UR, Pilewski JM, Kellum JA, Wenzel SE, Bayir H, Kagan VE, Bunimovich YL. Vats K, et al. Among authors: shah vk. J Clin Invest. 2024 Nov 21:e183219. doi: 10.1172/JCI183219. Online ahead of print. J Clin Invest. 2024. PMID: 39570671 Free article.
The TIPping point: Inflammation and Ionocyte loss.
Shah VS, Rajagopal J. Shah VS, et al. Respirology. 2024 Nov 19. doi: 10.1111/resp.14857. Online ahead of print. Respirology. 2024. PMID: 39562851 No abstract available.
3,629 results